Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study

Journal of Pediatric Gastroenterology and Nutrition 2026 Open access

Read full text
Authors: Steven J. Steiner, Jeremy Adler, Sawsan Saeed, Richard S Strauss, Kristin Howe, Anna Sheahan, Renping Zhang, Kimberly R Keihn, Katharine Harrow, Kelly K. Olano, David Evans, Kim Hung Lo
+5 more Nanhua Zhang, Lilianne Kim, Richard B. Colletti, S Volger, F. EpiSouth network
DOI: 10.1002/jpn3.70372
Cited by: 2
References: 23

Abstract

OBJECTIVES: Few approved treatments exist for children with Crohn's disease (CD). The REALITI study retrospectively assessed the effectiveness and safety of ustekinumab in real-world clinical settings for children with CD. METHODS: Data were collected from the prospective ImproveCareNow (ICN) registry for pediatric patients (≥ 2 to

Fields of Study & Subjects

Inflammatory Bowel Disease Pregnancy and Medication Impact Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Volume
82
Issue
5
Pages
1242–1250
Publication date
2 March 2026
Language
EN